Artificial Intelligence in Oncology Market Industry Trends and Global Forecasts to 2035, by Type of Cancer, Type of End-Users and Key Geographical Regions

The global artificial intelligence (AI) in oncology market is estimated to grow from USD 1.1 billion in the current year to USD 9.1 billion by 2035, at a CAGR of 21.4% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Cancer

• Solid malignancies
• Breast cancer
• Lung cancer
• Prostate cancer
• Colorectal cancer
• Brain tumor
• Others

Type of End Users

• Hospitals
• Pharmaceutical companies
• Research Institutes
• Others

Type of End Users

• North America
• Europe
• Asia-Pacific
• Rest of the World

Artificial Intelligence in Oncology Market: Growth and Trends

In the last decade, the popularity of AI has grown steadily. It has made a considerable impact on the overall medical healthcare sector, including in the field of oncology. This can be attributed to the surge in AI-based technologies for diagnosis and treatment. Given the breakthroughs in technological infrastructure and groundbreaking research, it is anticipated that AI is likely to overcome the complexities of medicine and has the potential to address the unmet needs within the pharmaceutical / biotech / medical devices domain. AI has demonstrated potential in improving tumor imaging diagnosis and therapy response evaluation, anticipating clinical outcomes, and accelerating drug development and translational oncology. AI has the potential to revolutionize the oncology sector by overcoming existing challenges and leveraging the power of big data to improve the cancer treatment further. Although AI is already being used in oncology clinical practice, ongoing and increased efforts are required to allow AI to reach its full potential. Driven by the continuous efforts of both industry and non-industry players to use AI based solutions in the oncology sector, the market is expected to witness sustainable growth in the foreseen future.

Artificial Intelligence in Oncology Market: Key Insights

The report delves into the current state of artificial intelligence in oncology market and identifies potential growth opportunities within the industry. Some key findings from the report include:

• The current market landscape features the presence of over 70 players engaged in the development of AI-based software solutions for the oncology sector.

• Over 50% of the players use their machine learning powered solutions for diagnostic purposes in hospitals; geographically, the software providers are well distributed.
• In pursuit of gaining a competitive edge, industry stakeholders are actively upgrading their existing capabilities and enhancing their AI focused service portfolios.
• The growing interest in this market is prevalent from the recent rise in partnership activity; ~50% of the deals were inked to enable utilization and integration of proprietary AI-based technology solutions.
• Foreseeing lucrative returns, many public and private investors have made investments worth ~USD 6 billion; 70% of the funding initiatives were led by venture capitalists.
• Over 2,770 patents have been granted / filed by academic and industry stakeholders in the last five years, exclusively for the development of AI-based software solutions for oncology.
• The market is expected to witness a healthy growth of over 21% in the coming decade; the opportunity is likely to be well distributed across various target indications, types of molecules and different regions.

Artificial Intelligence in Oncology Market: Key Segments

Solid Malignancies Segment is Likely to Dominate AI in Oncology Market During the Forecast Period

Based on the type of cancer, the market is segmented into solid malignancies, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumor, and others based on the type of cancer. At present, the solid malignancies segment holds the maximum share of the AI in oncology market. This trend is likely to remain the same in the coming decade.

Currently, Hospitals Segment Occupies the Largest Share of the AI in Oncology Market

Based on the type of end-user, the market is segmented into hospitals, pharmaceutical companies, research institutes and others. At present, the hospital segment holds the maximum share of the AI in oncology market. This trend is unlikely to change in the near future.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the world. Majority of the current AI in oncology market is captured by North America. It is worth highlighting that, over the years, the market in Europe is expected to grow at a higher CAGR.

Key Players in the Artificial Intelligence in Oncology Market, include:

• Berg
• Concert AI
• GE Healthcare
• IBM Watson Health
• iCAD
• JLK Inspection
• Median Technologies
• Path AI
• Roche Diagnostics

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:

• Chief Executive Officer, CancerCenter.AI
• Chief Executive Officer, Nucleai
• Chief Executive Officer, Visiopharm
• Vice President, Marketing and Communications, Enlitic

Artificial Intelligence in Oncology Market: Research Coverage

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the AI in oncology market, focusing on key market segments, including [A] type of cancer, [B] type of end-user and [C] key geographical regions.
• Market Landscape: A comprehensive evaluation of companies engaged in the development of AI in oncology-based software solutions, considering various parameters, such as [A] year of establishment, [B] company size (in terms of number of employees), [C] location of headquarters, [D] type of service(s) offered, [E] type of AI technology used, [F] type of platform and [G] type of end-user.
• Company Profiles: In-depth profiles of key industry players offering AI in oncology-based software solutions, focusing on [A] company overviews, [B] proprietary technology platform(s), [C] AI focused service portfolio, [D] recent developments and [E] an informed future outlook.
• Company Competitiveness Analysis: A comprehensive competitive analysis of companies engaged in the development of AI in oncology-based software solutions, examining factors, such as [A] supplier strength [B] portfolio diversity and [C] portfolio strength.
• Patent Analysis: Detailed analysis of various patents filed / granted related to AI in oncology-based software solutions based on [A] type of patent, [B] publication year, [C] geographical location / patent jurisdiction, [D] legal status, [E] CPC symbols, [F] type of industry, [G] type of applicant and [H] leading players (in terms of number of patents filed / granted). It also includes a detailed patent valuation analysis.
• Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2017, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] most active players (analysis by parent company and analysis by partner company), [D] type of partner, [E] type of cancer and [F] region.
• Funding and Investment Analysis: A detailed evaluation of the investments made in the ADC domain, encompassing seed financing, venture capital financing, debt financing, grants, IPOs and other offerings based on several parameters, such as [A] year of funding, [B] type of funding, [C] leading players (in terms of amount invested) and [D] key investors.
• Blue Ocean Strategy: A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in AI in oncology market to help unlock an uncontested market, featuring thirteen strategic tools that can help software developers to shift towards a blue ocean strategic market.

Key Questions Answered in this Report

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 10% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older